ES8601858A1 - Homologos de la aprotinina - Google Patents

Homologos de la aprotinina

Info

Publication number
ES8601858A1
ES8601858A1 ES534659A ES534659A ES8601858A1 ES 8601858 A1 ES8601858 A1 ES 8601858A1 ES 534659 A ES534659 A ES 534659A ES 534659 A ES534659 A ES 534659A ES 8601858 A1 ES8601858 A1 ES 8601858A1
Authority
ES
Spain
Prior art keywords
preparation
aprotinine
homologues
medicaments
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534659A
Other languages
English (en)
Other versions
ES534659A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19833339693 external-priority patent/DE3339693A1/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES534659A0 publication Critical patent/ES534659A0/es
Publication of ES8601858A1 publication Critical patent/ES8601858A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE HOMOLOGOS DE LA APROTININA. PARTIENDO DE APROTINA DE FORMULA (I), COMPRENDE: A) DISOCIAR EL ENLACE PEPTIDO ENTRE LISINA 15 Y ALANINA 16; B) ESTEARIFICAR LOS GRUPOS CARBOXILO LIBRES; C) REDUCIR EL PUENTE DISULFURO ENTRE LOS RESTOS CISTEINA 14 Y 38; D) HIDROLIZAR EL GRUPO ESTER EN LA LISINA 15; E) REESTABLECER EL PUNTE S-S ENTRE LOS RESTOS CISTEINA 14 Y 38; F) DISOCIAR EL RESTO DE LISINA 15; G CONDENSAR UN ESTER DE UNO DE LOS AMINOACIDOS GLICINA, L-ALANINA, L-VALINA, L-LEUCINA, L-ISOLEUCINA, L-METIONINA, L-ARGININA, ACIDO L-AMINOBUTIRICO, L-NORVALINA, L-NORLEUCINA, DEHIDROALANINA O L-HOMOSERINA, EN FORMA PEPTIDO EN LA CISTEINA 14; H) ESTABLECER NUEVAMENTE EL ENLACE PEPTIDO ENTRE LISINA 15 Y ALANINA 16; I) DISOCIAR LOS GRUPOS ESTER EN LOS GRUPOS CARBOXILICOS LIBRES; Y J) DISOCIAR CON HIDROXILAMINA, LOS GRUPOS 0-ACILUREA.
ES534659A 1983-07-28 1984-07-27 Homologos de la aprotinina Expired ES8601858A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3327277 1983-07-28
DE19833339693 DE3339693A1 (de) 1983-11-03 1983-11-03 Homologe des aprotinin mit anderen aminosaeuren in position 15 anstelle von lysin, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES534659A0 ES534659A0 (es) 1985-11-16
ES8601858A1 true ES8601858A1 (es) 1985-11-16

Family

ID=25812701

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534659A Expired ES8601858A1 (es) 1983-07-28 1984-07-27 Homologos de la aprotinina

Country Status (14)

Country Link
US (1) US4595674A (es)
EP (1) EP0132732B1 (es)
JP (1) JPH0686479B2 (es)
KR (1) KR890004784B1 (es)
AU (1) AU560584B2 (es)
CA (1) CA1238000A (es)
DE (1) DE3471940D1 (es)
DK (2) DK171895B1 (es)
ES (1) ES8601858A1 (es)
GR (1) GR82265B (es)
HU (1) HU199880B (es)
IE (1) IE57628B1 (es)
IL (1) IL72494A (es)
NZ (1) NZ209001A (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
US6132990A (en) * 1984-12-06 2000-10-17 Amgen Boulder Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
WO1986003497A1 (en) * 1984-12-06 1986-06-19 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.
GB2188322A (en) * 1986-03-26 1987-09-30 Bayer Ag Aprotinin and analogues thereof produced by a recombinant host
GB2188933A (en) * 1986-04-10 1987-10-14 Bayer Ag Expression vectors for production of polypeptides, method for enhanced expression of polypeptides, hosts containing the expression vectors, products manufactured thereby
US5187153A (en) * 1986-11-17 1993-02-16 Scios Nova Inc. Methods of treatment using Alzheimer's amyloid polypeptide derivatives
US5223482A (en) * 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
US5220013A (en) * 1986-11-17 1993-06-15 Scios Nova Inc. DNA sequence useful for the detection of Alzheimer's disease
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
US5032573A (en) * 1987-03-23 1991-07-16 Bayer Aktiengesellschaft Homologs of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
JP2656944B2 (ja) * 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化
DE3724570A1 (de) * 1987-06-27 1989-01-05 Bayer Ag Human-aprotinin, dessen lys-rest in position 15 gegen einen anderen protogenen aminosaeurerest ausgetauscht ist
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
US5591603A (en) * 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
US20060134087A1 (en) * 1988-09-02 2006-06-22 Dyax Corp. ITI-D1 Kunitz domain mutants as hNE inhibitors
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
ATE199090T1 (de) * 1989-03-06 2001-02-15 Univ Texas Gegenüber eigenen inhibitoren resistente t-pa mutanten
US5866413A (en) * 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
EP0401508B1 (de) * 1989-05-13 1994-11-23 Bayer Ag Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US7413537B2 (en) * 1989-09-01 2008-08-19 Dyax Corp. Directed evolution of disulfide-bonded micro-proteins
AU8740491A (en) * 1990-09-28 1992-04-28 Protein Engineering Corporation Proteinaceous anti-dental plaque agents
ATE431364T1 (de) * 1991-03-01 2009-05-15 Dyax Corp Inhibitoren der menschlichen elastase von neutrophilen
JP4146512B2 (ja) * 1991-03-01 2008-09-10 ダイアックス コープ． 小型タンパク質
US5747449A (en) * 1992-07-13 1998-05-05 Corvas International, Inc. Bovine pancreatic trypsin inhibitor derived inhibitors of factor XA
US6869925B1 (en) * 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
ATE277081T1 (de) 1994-01-11 2004-10-15 Dyax Corp Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
DE4417353A1 (de) * 1994-05-18 1996-01-25 Bayer Ag Verfahren zur Herstellung von rekombinantem Aprotinin und rekombinanten Aprotinin Varianten mit der natürlichen N-terminlaen Sequenz
DE19629982A1 (de) * 1996-07-25 1998-01-29 Bayer Ag Aprotinin-Varianten mit verbesserten Eigenschaften
GB0103765D0 (en) * 2001-02-15 2001-04-04 Affitech As Assay
WO2002078244A1 (en) * 2001-03-27 2002-10-03 Aware, Inc. Receiver transparent q-mode
AU2002358921A1 (en) * 2001-07-10 2003-04-28 Omnio Ab Novel drug targets for arthritis
ATE528014T1 (de) 2002-06-07 2011-10-15 Dyax Corp Polypeptid mit modifizierten kunitz domains
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
SI2386310T1 (sl) 2002-08-28 2019-03-29 Dyax Corp. Metode za ohranjanje organov in tkiv
DE602004031589D1 (de) * 2003-01-07 2011-04-14 Dyax Corp Kunitz-domäne-bibliothek
US6989369B2 (en) * 2003-02-07 2006-01-24 Dyax Corp. Kunitz domain peptides
US7432238B2 (en) * 2004-04-16 2008-10-07 Stc.Unm Human Kunitz-type inhibitor with enhanced antifibrinolytic activity
US7910550B2 (en) * 2004-04-16 2011-03-22 Stc.Unm Human kunitz-type inhibitor with enhanced antifibrinolytic activity
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
US20090223893A1 (en) * 2005-12-01 2009-09-10 Gjerde Douglas T Method and Device for Desalting an Analyte
US20060118491A1 (en) * 2004-12-03 2006-06-08 Gjerde Douglas T Method and device for desalting an analyte
EP3088522B1 (en) 2005-12-29 2017-11-29 The Regents of the University of California Methods and compositions related to mutant kunitz domain i of tfpi-2
WO2008110301A1 (de) * 2007-03-13 2008-09-18 Bayer Schering Pharma Aktiengesellschaft Aprotinin-varianten mit verbesserten eigenschaften
WO2010080833A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
HUE057244T2 (hu) 2010-01-06 2022-04-28 Takeda Pharmaceuticals Co Plazma kallikreint kötõ fehérjék
JP2014506257A (ja) 2011-01-06 2014-03-13 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
JP6719384B2 (ja) 2014-03-27 2020-07-15 ダイアックス コーポレーション 糖尿病黄斑浮腫の治療のための組成物および方法
US11286307B2 (en) 2015-12-11 2022-03-29 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Also Published As

Publication number Publication date
HU199880B (en) 1990-03-28
KR890004784B1 (ko) 1989-11-27
JPS6056999A (ja) 1985-04-02
US4595674A (en) 1986-06-17
IL72494A0 (en) 1984-11-30
ES534659A0 (es) 1985-11-16
IL72494A (en) 1988-02-29
GR82265B (es) 1984-12-13
AU560584B2 (en) 1987-04-09
DK171441B1 (da) 1996-10-28
DK369284A (da) 1985-01-29
EP0132732A3 (en) 1986-02-05
AU3000184A (en) 1985-01-31
DK60993D0 (da) 1993-05-27
EP0132732B1 (de) 1988-06-08
DE3471940D1 (en) 1988-07-14
JPH0686479B2 (ja) 1994-11-02
NZ209001A (en) 1989-02-24
EP0132732A2 (de) 1985-02-13
CA1238000A (en) 1988-06-14
KR850001288A (ko) 1985-03-18
IE841954L (en) 1985-01-28
DK369284D0 (da) 1984-07-27
IE57628B1 (en) 1993-02-10
HUT34515A (en) 1985-03-28
DK171895B1 (da) 1997-08-04
DK60993A (da) 1993-05-27

Similar Documents

Publication Publication Date Title
ES8601858A1 (es) Homologos de la aprotinina
ATE124997T1 (de) Enzymatische entfernung einer aminoterminalen proteinsequenz.
PT822199E (pt) Polipeptidos monopegilados no terminal-n e metodo para a sua preparacao
SG52088G (en) Novel pharmaceutical composition based on valproic acid and its production process
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
PT975761E (pt) Interferao beta humano recombinante com solubilidade melhorada
GB8700204D0 (en) Pancreatic secretory trypsin inhibitor & variants
IL66256A0 (en) Water containing compositions comprising salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
SE8901041L (sv) Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning
ES8607243A1 (es) Esteres de aminoacidos y de peptidos cromogenos
ES8307491A1 (es) Un metodo para preparar una composicion de gel acuoso semi- solido para alimentacion de heridos
EP0225020A3 (en) Peptides comprising, in sequence, units selected from the amino-acid residues 17 to 24 of vip
IE830529L (en) Insulins from preproinsulins
EP0330700A4 (en) Human prourokinase-like polypeptide.
EP0373540A3 (en) Method for purifying fibroblast growth factor protein
FR2556593B1 (fr) Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels
EP0199568A3 (en) Method for purifying interferon and composition of matter produced thereby
ATE105841T1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
IT1164240B (it) Decapeptide parzialmente retro-invertito inibitore specifico della renina con elevata resistenza alla idrolisi enzimatica
ES2002015A6 (es) Un procedimiento para la preparacion de nuevos acidos y esteres ((((3-piridinil)metilen)amino)oxi)alcanoicos.
AR243865A1 (es) Procedimientos para fabricar derivados de aminoacidos; y silil derivados de aminoacidos utiles como intermediarios en dicho procedimiento.
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
PT84694B (pt) Processo para a preparacao de composicoes cardiovasculares topicas contendo um ester de acido nitrico
JPS5564556A (en) Novel thyroliberine derivative